EUVIMEDScopri EUVIMED
Leserbrief

Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply

Sara Cmet, Edmondo Falleti, Elisabetta Degasperi iD, Pietro Lampertico iD, Pierluigi Toniutto iD

Alimentary Pharmacology & Therapeutics · 2026-10-30

DOI: 10.1111/apt.71081 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-10-30. Written by Sara Cmet and 4 co-authors. Institution: Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Udine, Italy. 5 references.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Authors and institutions

  • Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Udine, Italy.
  • Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • CRC 'A. M. And A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

ORCID profiles: Elisabetta Degasperi, Pietro Lampertico, Pierluigi Toniutto

Cite

APA

Cmet, S., Falleti, E., Degasperi, E., Lampertico, P., & Toniutto, P. (2026). Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71081

Vancouver

Cmet S, Falleti E, Degasperi E, Lampertico P, Toniutto P. Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71081

BibTeX
@article{Cmet2026,
  author = {Cmet, Sara and Falleti, Edmondo and Degasperi, Elisabetta and Lampertico, Pietro and Toniutto, Pierluigi},
  title = {Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71081}
}
Start for free →